File: EWHealth Care · Large capCLIPPED · 2026-11-05
EWEdwards Lifesciences
Mkt cap $50B
Sector benchmark XLV
Sector benchmark XLV
100.82
+1.5%
±5.1%into Nov 2095.67–105.97±5.1%monthly95.67–105.97Pullback · CandidateKnife · TurnedMomentum · —DP short-vol · 44% ▾ easing
Price · 6 months · daily
6m high100.82
6m low77.17
Vol vs 20d avg2.1× · heavy
Off 52-wk high0.0%
EW dark pool FINRA · T+1
13Selection score
frozen logit · OOS +0.145R · one era
frozen logit · OOS +0.145R · one era
Short-vol ratio44% · easing
Off-exchange share38%
vs own 1-yr (z)0.9
EW sector RS vs XLV
+0.7%vs XLV · 63 sessions
EW vs XLV · 3m+0.7%
EW vs XLV · 6m−4.7%
ratio of closes, rebased — a relative read, not a peer percentile
EW gamma profile CBOE delayed
Call wall97.50
Put wall100.00
Dealer posturelong gamma · dampens moves
nearest expiry 2026-11-20 · as of 2026-11-05 · heuristics · full profile →
EW fundamentals SEC filings · TTM
P/Etrailing57x
P/Elast FY54x
P/E3-yr median32x
EPStrailing$1.74
EPSFY to Dec 2025$1.83
Revenue$6.5B · +15%
Income$1.0B · −76%
Margin22.3%
10-Q · filed 4 Aug 2026 · Fundamentals as of 2026-11-04 · latest session 2026-11-05
EW earnings reactions two-session move
3.3%typical move
Oct 2023 → Jul 2026
Revenue and profit by quarter
PriceRevenueProfit
$3.1B
FY23 Q4
FY24 Q2
FY24 Q4
FY25 Q2
FY25 Q4
FY26 Q2
P/E history
PriceP/E3-yr median
EW dividends per share · Yahoo · SEC
No dividend.
EW gamma history nightly
25 Sep → 5 Nov · full history →
EW session over session 4 Nov → 5 Nov
Expected move · monthly 20 Nov5.11%−1.91 pp
Call and put wallheld their strikes
full listed chain, a separate capture from the gamma panel · CBOE delayed
Auto-note // The 97.50 call wall is the nearest-expiry ceiling heuristic; 100.00 is the floor. Options price ±5.1% into Nov 20. Dark-pool short volume at 44% and easing vs its 20-day. The pullback screen flagged a reclaim candidate on Nov 2. The falling-knife screen has it turned after a 16% sell-off.
Composed from the nightly pipelines — every panel degrades independently when its dataset is missing. Heuristics labeled as heuristics; not investment advice.